Osteoscopic Surgery of Giant Cell Tumor of Bone for Preservation of Proximal Fibula

Futani, Hiroyuki; Kumanishi, Shunsuke; Minakawa, G O; Yoshiya, Shinichi

doi:10.21873/anticanres.12552

Cited by 5 publications

(8 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In the long bones group, image intensifier was utilised for all 13 patients [5], [7]. Among them, 8 patients underwent the procedure with endoscope or osteoscope through a small incision, and the other 5 patients did not have additional visualisation inside the lesion [6], [8], [9]. The indication for studies of MIS of GCT in axial bones was tumours with high morbidity and failed conventional treatment [5], [7].…”

Section: Resultsmentioning

confidence: 99%

“…The indication for studies of MIS of GCT in axial bones was tumours with high morbidity and failed conventional treatment [5], [7]. As for studies of long bones GCT, special attention was given to lesions around joint and one that still has cortical wall even though thin [6], [8], [9]. The summary of used methods and their indications were described in Table 2.…”

Section: Resultsmentioning

confidence: 99%

“…The other highlight of this technique is the use of magnification with equipment which provides excellent visualisation of the bone cavity. Direct visualisation can be provided by osteoscopy or endoscopy which magnifies the inside of lesion onto large monitors, enabling surgeons to identify small residual tumours [6], [9]. Additionally, the computer navigation system can also be used to confirm whether the curettage is already as thorough as a preoperative plan [6].…”

Section: Mis For Gct Near Joint Of Long Bonesmentioning

confidence: 99%

“…Whereas in argon beam coagulator technique for treating GCT of axial bones, there is a risk of damaging neural tissue, when the tip of the nozzle is initiated before reaching at least 1 cm of the tissue surface [7]. For extraskeletal lesions, osteoscopic surgery method should also be used cautiously, where if the lesion fails to create a sclerotic wall using denosumab, then this method is no longer suitable to apply [9]. In general, MIS requires surgeons who are well-adapted to endoscopic and navigation surgeries.…”

Section: Limitation Of Mismentioning

confidence: 99%

See 3 more Smart Citations

Efficacy of Minimally Invasive Surgery on Giant Cell Tumour of the Bone: A Systematic Review

Deslivia

Savio

Dharmapradita

et al. 2019

Open Access Maced J Med Sci

View full text Add to dashboard Cite

BACKGROUND: Although major reconstructive surgeries in the form of excision and reconstruction have been the mainstay treatment for Giant Cell Tumour (GCT) of the bone, its recurrence rate remains high and poses various morbidities such as implant failure or skin breakdown. Minimal invasive surgery (MIS) techniques, which has gained popularity mostly in other fields in orthopaedic surgery, are being introduced as an alternative to limit the surgical complications while achieving the best possible outcome. Until now, there has been no literature summarising the evidence of MIS outcome in treating GCT of the bone. AIM: The purpose of this systematic review was to investigate the efficacy of this relatively new treatment. METHODS: We comprehensively searched PubMed, EMBASE, and Cochrane Library to search for studies about MIS for GCT of the bone treatment up to March 1, 2019. The selection of appropriate studies was performed by two independent investigators based on PRISMA guideline. Given the limited number of studies, there was no restriction in terms of patient’s demographics, the specific minimally invasive surgical method, and publication status. RESULTS: We found 120 articles from the database. After evaluating full text, 5 articles (16 patients) were found to be eligible. The minimally invasive methods were curettage, cryosurgery, and argon beam coagulator. The visualisation methods include a computer-assisted navigation system, endoscope, otoscope, CT, and MRI. Location of tumours includes axial and long bones. The follow-up period ranges from 7 to 126 months. The functional and oncological outcome was found to be satisfying with no recurrence or complications. CONCLUSION: In conclusion, MIS is a familiar method in orthopaedic surgery with potential expansion in tumour field. The current evidence shows that this approach for GCT results in good functional outcome, with low risk of recurrence.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Mis For Gct Near Joint Of Long Bonesmentioning

confidence: 99%

Section: Limitation Of Mismentioning

confidence: 99%

See 2 more Smart Citations

Efficacy of Minimally Invasive Surgery on Giant Cell Tumour of the Bone: A Systematic Review

Deslivia

Savio

Dharmapradita

et al. 2019

Open Access Maced J Med Sci

View full text Add to dashboard Cite

show abstract

“…Several case series reported the use of minimally invasive curettage (MIC) on GCTB. 4 , 5 , 6 , 7 The use of endoscopy and computer navigation has been reported to assist in intralesional curettage of benign bone tumors. 4 It helped assess tumor clearance with magnified endoscopic images and CT images under navigation guidance.…”

Section: Introductionmentioning

confidence: 99%

Local Recurrence After Minimally Invasive Curettage For Primary Giant Cell Tumor of Bone With Perioperative Bisphosphonate Is Comparable to Open Curettage: Retrospective Comparison With 9-Year Follow-Up

Lau

Wong

Chiu

et al. 2021

Arthroscopy, Sports Medicine, and Rehabilitation

View full text Add to dashboard Cite

Purpose: To compare the long-term oncological outcome of minimally invasive curettage (MIC) with conventional open curettage (OC). Methods: We studied patients with primary giant cell tumor of bone (GCTB) of extremities who underwent intralesional tumor curettage and cementation and perioperative bisphosphonates from February 2003 to June 2016. All cases were histology-confirmed diagnoses of GCTB. Recurrent GCTB, malignant GCTB, cases in the axial skeleton (pelvis and spine), or cases with bone grafting of the curetted cavity were excluded. The local recurrence-free (LR-free) estimates of the OC and MIC groups were compared. The hazard ratio of a local recurrence was calculated for the various factors of the patients, disease, and treatment. Results: At a mean follow-up of 8.8 years, the overall LR rate was 24.2% (8 out of 33 patients). There was no statistical difference in LR in MIC and OC groups (27.8 % vs 20%; P ¼ .6). The mean time to LR was 33.1 months (8 to 75). The operative time was comparable in both MIC and OC groups. None of the risk factors studied led to a significantly higher hazard of LR. Conclusion: At a long-term follow-up of 9 years, MIC showed similar LR-free survival to OC. Combining bisphosphonates and MIC with a less invasive approach showed reasonable LR-free survival in long-term follow-up.

show abstract

Osteoscopic versus open surgery for the treatment of enchondroma in the foot

Futani

Kawaguchi

Sawai

et al. 2023

Arch Orthop Trauma Surg

View full text Add to dashboard Cite

Osteoscopic Surgery of Giant Cell Tumor of Bone for Preservation of Proximal Fibula

Abstract: Osteoscopic surgery is feasible for immediate and complete recovery, and can improve quality of life for patients with GCTB of the proximal fibula with satisfactory oncological outcome.

Cited by 5 publications

References 18 publications

Efficacy of Minimally Invasive Surgery on Giant Cell Tumour of the Bone: A Systematic Review

Efficacy of Minimally Invasive Surgery on Giant Cell Tumour of the Bone: A Systematic Review

Local Recurrence After Minimally Invasive Curettage For Primary Giant Cell Tumor of Bone With Perioperative Bisphosphonate Is Comparable to Open Curettage: Retrospective Comparison With 9-Year Follow-Up

Osteoscopic versus open surgery for the treatment of enchondroma in the foot

Contact Info

Product

Resources

About